Subscribe to Newsletter
Subspecialties Retina

Written in Blood

Early melanoma detection, both of the eye and skin, can dramatically increase the chances of successful treatment. Unfortunately, nevi at the back of the eye are quite common and tend to mimic early signs of the disease. Now, scientists have discovered microRNA biomarkers in the blood that can differentiate between benign nevi and melanoma, as well as identify whether the cancer has metastasized.

“Our research aimed to facilitate the clinical decision process by providing a simple blood test that will enable monitoring of nevi and reduce the need for intense surveillance,” said Mitchell Stark, the lead author of the study from the University of Queensland Dermatology Research Centre, Australia. The test would be used by optometrists, GPs and specialists to monitor biomarker levels in the blood over time and alert them to high-risk patients that may need further tests. The next step is to validate the findings with an independent study and assess the clinical utility of the test.

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Lauren Robertson

Deputy Editor at The Ophthalmologist.

Related Product Profiles
Uncover the Unique DNA of SPECTRALIS®

| Contributed by Heidelberg Engineering

Subspecialties Retina
ForeseeHome® – remote monitoring to help detect wet AMD earlier and improve outcomes

| Contributed by Notal Vision

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Here
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: